Uncategorized Archives - CannabisNewsWire

FridayAug 21, 2026 4:20 pm

420 with CNW – Could MMJ Be Mailed Once Federal Rescheduling Is Completed?

Georgia regulators are considering whether licensed medical cannabis dispensaries should be permitted to send products directly to registered patients through the mail, a move that could make treatment more accessible across the state. The Georgia Access to Medical Cannabis Commission is scheduled to discuss the proposal at a public meeting on September 16. The plan would apply only to shipments between licensed Georgia dispensaries and patients located within the state. Commission officials say recent changes in federal cannabis policy may provide legal grounds for such deliveries. Medical cannabis that complies with state regulations was reclassified as a Schedule III controlled substance under federal law earlier this year. Regulators…

ThursdayAug 20, 2026 4:20 pm

420 with CNW – Study Finds That Marijuana Legalization Boosts Jobs in Agriculture Sector

States that legalize cannabis tend to record stronger agricultural employment growth than they otherwise would have experienced, according to new research from economists at Texas Tech University. The study, presented at the 2026 Agricultural and Applied Economics Association conference, found that agricultural employment rose by roughly 9% following cannabis legalization. However, the increase in jobs was not accompanied by a comparable rise in pay. Researchers said the wage pattern likely reflects broader labor-market dynamics rather than a direct consequence of marijuana policy. For the analysis, researchers examined state-level information collected by the U.S. Bureau of Labor Statistics through its Quarterly Census of Employment and Wages. The dataset…

TuesdayAug 18, 2026 4:20 pm

420 with CNW — Alcohol Wholesalers and Retailers Back Measure to Keep Hemp-Derived THC Drinks Legal

Major alcohol distributors and retailers are supporting bipartisan legislation that would establish a federal regulatory system for hemp-derived THC beverages rather than subject them to a looming prohibition. The Beverage Regulatory Parity Act, introduced by Reps. Greg Landsman and Beth Van Duyne, would allow certain hemp drinks to remain on the market while placing them under taxation, testing, labeling, and sales requirements modeled partly on the alcohol industry. The Wine and Spirits Wholesalers of America has endorsed the proposal. Dawson Hobbs, the group’s executive VP for government affairs, said hemp beverages with controlled THC levels should be sold within a…

WednesdayJul 15, 2026 4:20 pm

420 with CNW — Study Shows Restless Legs Syndrome Patients Benefit from Medical Marijuana

A new study suggests that marijuana-based treatment may provide lasting relief for people living with restless legs syndrome (RLS). RLS causes an overwhelming urge to move the legs and disrupts sleep. The disorder affects an estimated 7 to 12 percent of adults in North America and Europe and is more frequent among those with multiple sclerosis. For many years, dopamine agonists have been considered the primary therapy for RLS. More recently, however, research has shifted toward gabapentinoids as a preferred option. Since cannabinoids and gabapentinoids influence similar biological pathways involving certain amino acids linked to the condition, researchers wanted to determine whether cannabis compounds could also ease symptoms. The open-label study enrolled adults with long-term RLS whose symptoms had persisted despite…

TuesdayJul 14, 2026 4:20 pm

420 with CNW — Wyoming Snubs Federal Marijuana Reclassification, Retains Marijuana Under Schedule I

Wyoming will retain cannabis and related products under the state’s most restrictive controlled substance category, declining to follow a recent federal change that shifted some cannabis-based products into a lower category. The state Attorney General’s Office announced that Wyoming’s Commissioner of Drugs and Substances Control issued a final order opposing the federal reclassification. The federal action stemmed from a rule released by the DOJ on April 28. Under that rule, cannabis contained in products approved by the FDA, along with products associated with state-regulated medical cannabis programs, was moved to Schedule III under the CSA. The change also covered certain…

WednesdayJul 08, 2026 4:20 pm

420 with CNW — DEA Opens Rescheduling Hearing by Expressing Support for Reclassification

Federal officials used the opening day of a closely watched administrative hearing on June 29 to reaffirm their support for a proposal that would move marijuana to Schedule 3 under federal law. Speaking at the DEA’s headquarters in Arlington, Virginia, James J. Schwartz, an attorney with the agency’s Office of Chief Counsel, said the federal government continues to back the proposed change. He told the administrative law judge overseeing the proceedings that the government would present expert testimony to support the recommendation to reclassify marijuana under the Controlled Substances Act. Schwartz said the government’s role in the hearing is to…

TuesdayJun 09, 2026 4:20 pm

420 with CNW — Kentucky Governor Broadens List of MMJ Qualifying Conditions

Kentucky Governor Andy Beshear has moved to broaden access to the state’s medical cannabis program, signing an executive order that expands the range of medical conditions eligible for treatment and renewing his call for wider marijuana reform. Speaking at a news conference last week, Beshear said the action is intended to provide greater clarity around Kentucky’s existing medical cannabis law. According to the governor, the current statute already allows marijuana to be recommended for symptoms such as nausea and chronic pain. His order makes it clear that patients diagnosed with illnesses commonly associated with those symptoms may also qualify for…

MondayJun 01, 2026 4:20 pm

420 with CNW — DEA Prepares for Hearings on Federal Marijuana Rescheduling

Federal regulators are moving closer to a key decision on cannabis policy as the DEA prepares to hold a hearing in June on the reclassification of marijuana under national law. The proceedings have already attracted interest from groups on both sides of the legalization debate, highlighting the continuing divide over cannabis reform in the U.S. Advocacy organizations supporting legalization, including NORML, have officially signaled plans to join the hearing. At the same time, anti-legalization voices such as Smart Approaches to Marijuana are also expected to take part. The event represents another important stage in the long-running effort to reconsider marijuana’s…

FridayMay 29, 2026 4:20 pm

420 with CNW — Missouri Regulators Prepare Final Marijuana License Lottery

Missouri cannabis regulators are preparing for a statewide outreach effort ahead of the final lottery that will distribute 77 microbusiness marijuana permits, with officials hoping recent policy changes will strengthen oversight and reduce problems that have troubled earlier rounds. Throughout June, Missouri’s marijuana regulatory division chief equity officer Lesley Turek plans to host informational sessions in St. Louis, Kansas City, and Jefferson City along with five virtual events. The meetings are intended to guide prospective applicants through the process, explain eligibility standards and answer questions before submissions begin later this summer. A key focus of the presentations will be new regulations scheduled to take effect at…

FridayMay 15, 2026 4:20 pm

420 with CNW — Study Suggests Marijuana Could Boost Weight Loss, Support Metabolic Health

A new preclinical investigation from the University of California, Riverside, is offering fresh insight into a puzzling trend researchers have observed for years: people who regularly use cannabis often show lower body weight and a smaller likelihood of developing type 2 diabetes, even though marijuana is widely known to stimulate hunger. Led by Professor Nicholas V. DiPatrizio of the UCR School of Medicine, the research explored why long-term marijuana users frequently show healthier metabolic patterns than non-users, despite the drug’s reputation for triggering cravings and overeating. The study focused on how different cannabis compounds influence body weight and blood sugar…